Clients in the Media Found 2 Results November 4, 2025 | Sparrow Pharmaceutials BIO-Europe 2025: Sparrow Pharmaceuticals raised a $95M series B last month – it will be testing its cortisol depleting HSD1 inhibitor in treatment-resistant type 2 diabetes BiotechTV November 3, 2025 | Abivax BIO-Europe 2025: Abivax CEO Marc de Garidel discusses physician and payor feedback after obefazimod’s phase 3 UC induction readouts, and next steps regarding maintenance and Crohn’s BiotechTV